Bokf, Na Moderna, Inc. Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Moderna, Inc. stock. As of the latest transaction made, Bokf, Na holds 15,789 shares of MRNA stock, worth $635,823. This represents 0.02% of its overall portfolio holdings.

Number of Shares

15,789

Previous 15,717 0.46%

Holding current value

$635,823

Previous $1.87 Million 43.46%

% of portfolio

0.02%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $4,582 - $9,010	72 Added 0.46%	15,789 $1.06 Million
Q2 2024 Aug 07, 2024	SELL	$101.21 - $166.61 $86,332 - $142,118	-853 Reduced 5.15%	15,717 $1.87 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $53,356 - $72,150	-625 Reduced 3.63%	16,570 $1.77 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $317,799 - $477,453	4,572 Added 36.22%	17,195 $1.71 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $760,289 - $998,446	7,886 Added 166.48%	12,623 $1.3 Million
Q2 2023 Aug 21, 2023	SELL	$118.5 - $160.53 $1.3 Million - $1.76 Million	-10,991 Reduced 69.88%	4,737 $575,000
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $1.47 Million - $2.13 Million	-10,816 Reduced 40.75%	15,728 $2.42 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $1.15 Million - $2.03 Million	-9,688 Reduced 26.74%	26,544 $4.77 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $316,191 - $520,014	2,678 Added 7.98%	36,232 $4.28 Million
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $170,424 - $256,938	-1,455 Reduced 4.16%	33,554 $4.79 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $2.06 Million - $3.84 Million	16,328 Added 87.4%	35,009 $6.03 Million
Q4 2021 Mar 11, 2022	BUY	$225.82 - $368.51 $1.59 Million - $2.6 Million	7,052 Added 60.64%	18,681 $4.75 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $906,683 - $1.98 Million	4,086 Added 54.17%	11,629 $4.48 Million
Q1 2021 Apr 21, 2021	BUY	$109.18 - $185.98 $823,544 - $1.4 Million	7,543 New	7,543 $988,000
Q1 2020 May 13, 2020	SELL	$17.78 - $31.58 $476,877 - $847,007	-26,821 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$13.93 - $21.28 $150,193 - $229,440	-10,782 Reduced 28.67%	26,821 $524,000
Q3 2019 Nov 13, 2019	BUY	$12.26 - $18.07 $461,012 - $679,486	37,603 New	37,603 $598,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account